Literature DB >> 7555181

Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.

J Hirsh, R Raschke, T E Warkentin, J E Dalen, D Deykin, L Poller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7555181     DOI: 10.1378/chest.108.4_supplement.258s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  49 in total

Review 1.  Antithrombin agents as adjuncts to thrombolytic therapy.

Authors:  J K French; H D White
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

2.  Hemostasis Laboratory: Assays for Platelet Function and Von Willebrand Disease.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-09       Impact factor: 2.300

Review 3.  Argatroban.

Authors:  Sekar Kathiresan; Jin Shiomura; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2002-02       Impact factor: 2.300

Review 4.  How We Manage Pediatric Deep Venous Thrombosis.

Authors:  Marisol Betensky; Mark A Bittles; Paul Colombani; Neil A Goldenberg
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

5.  Low-Molecular-Weight Heparin in the Initial Treatment of Proximal Deep Vein Thrombosis.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 6.  Tissue Engineering at the Blood-Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development.

Authors:  Daniel Radke; Wenkai Jia; Dhavan Sharma; Kemin Fena; Guifang Wang; Jeremy Goldman; Feng Zhao
Journal:  Adv Healthc Mater       Date:  2018-05-07       Impact factor: 9.933

Review 7.  Recommendations for anticoagulated patients undergoing image-guided spinal procedures.

Authors:  Kennith F Layton; David F Kallmes; Terese T Horlocker
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

8.  Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.

Authors:  J Petäjä; J A Fernández; A Gruber; J H Griffin
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

Review 9.  Low molecular weight heparins: a guide to their optimum use in pregnancy.

Authors:  Pierre Laurent; Guy-Vincent Dussarat; Jacques Bonal; Christophe Jego; Philippe Talard; Christian Bouchiat; Gilles Cellarier
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 10.  Anticoagulation therapy in children.

Authors:  Milind D Ronghe; Christina Halsey; Nicholas J Goulden
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.